Phase II Clinical Trial of COVID-19 mRNA Vaccine in Adults Aged 18 Years and Older

NCT05373472 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
150
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

CanSino Biologics Inc.